Industry Reports
Forecast: Bioinformatics Industry Will Reach $31.71B By 2031
As per new market research that’s titled 'Bioinformatics Market Size, Share, Forecast, & Trends Analysis by Solutions & Services (Knowledge Management, Sequence Analysis, Data Analysis) Application (Genomics, Metabolomics, Transcriptomics) Industry (Health, Agriculture) – Global Forecast to 2031, the bioinformatics...
Industry Reports
Booming Pharma Industry of India: A Review of Quarter1 2023
Pharmaceutical companies are turning their attention to the Indian market as revenues decline in the US, Europe, and emerging markets. Indian companies like Sun Pharma, Dr. Reddy's, and Cipla are eyeing the domestic market for solid revenues. The Indian...
Drug Research
Rapid Expansion Projected In Pharma Sterility Testing Market
Recent insights suggest that the pharmaceutical sterility testing market is projected to grow from $0.636 billion in 2023 to $1.0223 billion by 2032. Factors such as the increasing emphasis on quality and sterility, government investments, and the introduction of...
Industry Reports
UK Unleashes £650 Million For Life Sciences Growth Package
The UK chancellor has gone on to announce a £650 million growth package in life sciences so as to help in delivering the science and technology framework by way of boosting investment, reforming regulation as well as driving up...
Industry Reports
Sharing Sustainable Best Practices
To commit to sustainability & social responsibility as a globally operating organization requires transparency and accountability. We experienced in the last couple of years how responsible action positively impacts our stakeholders as well as the society overall, and these...
Industry Reports
Bormioli Pharma reaffirms its commitment to environmental and social sustainability with the presentation of the 2nd edition of its ESG Report
Bormioli Pharma, a leading international manufacturer of pharmaceutical packaging and medical devices, today presented the second edition of its Sustainability Report.
This edition aims to reaffirm and consolidate the company's commitment to environmental and social responsibility, protecting the wellbeing of people and the environment,...
Industry Reports
Significant Cost Savings A Possibility With Biosimilars
According to the AHIP report, savings from biosimilars are assumed to exceed $180 billion over the next five years, representing a four-fold increase over savings from the previous five years. In line with the report, considerations should be made...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read